KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zoetis (ZTS) EBT (2016 - 2026)

Zoetis has reported EBT over the past 14 years, most recently at $761.0 million for Q4 2025.

  • Quarterly EBT rose 3.96% to $761.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 billion through Dec 2025, up 7.25% year-over-year, with the annual reading at $3.4 billion for FY2025, 7.25% up from the prior year.
  • EBT was $761.0 million for Q4 2025 at Zoetis, down from $887.0 million in the prior quarter.
  • Over five years, EBT peaked at $902.0 million in Q2 2025 and troughed at $506.0 million in Q4 2021.
  • The 5-year median for EBT is $722.0 million (2022), against an average of $728.6 million.
  • Year-over-year, EBT skyrocketed 38.23% in 2021 and then dropped 10.55% in 2024.
  • A 5-year view of EBT shows it stood at $506.0 million in 2021, then rose by 17.0% to $592.0 million in 2022, then grew by 9.8% to $650.0 million in 2023, then rose by 12.62% to $732.0 million in 2024, then grew by 3.96% to $761.0 million in 2025.
  • Per Business Quant, the three most recent readings for ZTS's EBT are $761.0 million (Q4 2025), $887.0 million (Q3 2025), and $902.0 million (Q2 2025).